BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 15967921)

  • 1. Early detection of thick melanomas in the United States: beware of the nodular subtype.
    Demierre MF; Chung C; Miller DR; Geller AC
    Arch Dermatol; 2005 Jun; 141(6):745-50. PubMed ID: 15967921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thick melanoma: the problem continues.
    Tejera-Vaquerizo A; Mendiola-Fernández M; Fernández-Orland A; Herrera-Ceballos E
    J Eur Acad Dermatol Venereol; 2008 May; 22(5):575-9. PubMed ID: 18081751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thick melanoma: the challenge persists.
    Murray CS; Stockton DL; Doherty VR
    Br J Dermatol; 2005 Jan; 152(1):104-9. PubMed ID: 15656809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The contribution of nodular subtype to melanoma mortality in the United States, 1978 to 2007.
    Shaikh WR; Xiong M; Weinstock MA
    Arch Dermatol; 2012 Jan; 148(1):30-6. PubMed ID: 21931016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The thickness of melanomas has decreased in central Italy, but only for thin melanomas, while thick melanomas are as thick as in the past.
    Crocetti E; Caldarella A; Chiarugi A; Nardini P; Zappa M
    Melanoma Res; 2010 Oct; 20(5):422-6. PubMed ID: 20679908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of detection of superficial spreading and nodular-type melanoma: a multicenter Italian study.
    Carli P; De Giorgi V; Palli D; Maurichi A; Mulas P; Orlandi C; Imberti G; Stanganelli I; Soma P; Dioguardi D; Catricalá C; Betti R; Paoli S; Bottoni U; Lo Scocco G; Scalvenzi M; Giannotti B
    Dermatol Surg; 2004 Nov; 30(11):1371-5; discussion 1375-6. PubMed ID: 15522016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors related to the presentation of thin and thick nodular melanoma from a population-based cancer registry in Queensland Australia.
    Geller AC; Elwood M; Swetter SM; Brooks DR; Aitken J; Youl PH; Demierre MF; Baade PD
    Cancer; 2009 Mar; 115(6):1318-27. PubMed ID: 19189368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation in incidence and fatality of melanoma by season of diagnosis in new South Wales, Australia.
    Boniol M; Armstrong BK; Doré JF
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):524-6. PubMed ID: 16537711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in melanoma epidemiology suggest three different types of melanoma.
    Lipsker D; Engel F; Cribier B; Velten M; Hedelin G
    Br J Dermatol; 2007 Aug; 157(2):338-43. PubMed ID: 17596175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant melanoma of the head and neck in Scotland: an eight-year analysis of trends in prevalence, distribution and prognosis.
    Cox NH; Jones SK; MacKie RM
    Q J Med; 1987 Aug; 64(244):661-70. PubMed ID: 3444872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002.
    Coory M; Baade P; Aitken J; Smithers M; McLeod GR; Ring I
    Cancer Causes Control; 2006 Feb; 17(1):21-7. PubMed ID: 16411049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes from mid-1980s to late 1990s among clinical and demographic correlates of melanoma thickness.
    Crocetti E; Carli P
    Eur J Dermatol; 2003; 13(1):72-5. PubMed ID: 12609787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biology of desmoplastic melanoma: a case-control comparison with other melanomas.
    Livestro DP; Muzikansky A; Kaine EM; Flotte TJ; Sober AJ; Mihm MC; Michaelson JS; Cosimi AB; Tanabe KK
    J Clin Oncol; 2005 Sep; 23(27):6739-46. PubMed ID: 16170181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of cutaneous melanoma in the United States by histology with special reference to the face.
    Newell GR; Sider JG; Bergfelt L; Kripke ML
    Cancer Res; 1988 Sep; 48(17):5036-41. PubMed ID: 3409232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thick malignant melanoma is a long-term problem.
    Asquith PR; Barnett JM; Lockett BK
    N Z Med J; 1999 Aug; 112(1094):313-6. PubMed ID: 10493441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.
    Buettner PG; Leiter U; Eigentler TK; Garbe C
    Cancer; 2005 Feb; 103(3):616-24. PubMed ID: 15630700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dubreuilh melanoma: and epidemiologic and prognostic study].
    Tournillac I; Picot MC; Dereure O; Guilhou JJ; Guillot B
    Ann Dermatol Venereol; 1999 Oct; 126(10):676-80. PubMed ID: 10604003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The incidence and thickness of cutaneous malignant melanoma in New Zealand 1994-2004.
    Richardson A; Fletcher L; Sneyd M; Cox B; Reeder AI
    N Z Med J; 2008 Aug; 121(1279):18-26. PubMed ID: 18709044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary malignant melanoma of skin in four regions of New Zealand.
    Cooke K; McNoe B; Hursthouse M; Taylor R
    N Z Med J; 1992 Aug; 105(939):303-6. PubMed ID: 1501812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous malignant melanoma in young adults under age 30.
    Tamir G; Milo Y; Rothem A; Sulkes J; Hauben DJ
    Isr J Med Sci; 1996 Dec; 32(12):1290-6. PubMed ID: 9007174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.